{"id":"https://openalex.org/W4416844611","doi":"https://doi.org/10.1158/1078-0432.30750483","title":"Supplementary Figure 7 from A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors","display_name":"Supplementary Figure 7 from A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors","publication_year":2025,"publication_date":"2025-12-01","ids":{"openalex":"https://openalex.org/W4416844611","doi":"https://doi.org/10.1158/1078-0432.30750483"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30750483","doi":"https://doi.org/10.1158/1078-0432.30750483","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30750483","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30750483","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068026508","display_name":"Geoffrey Yuyat Ku","orcid":"https://orcid.org/0000-0002-0448-1038","observed_orcids":["https://orcid.org/0000-0002-0448-1038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey Ku","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0448-1038","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073838859","display_name":"Lin Shen","orcid":"https://orcid.org/0000-0002-8798-4756","observed_orcids":["https://orcid.org/0000-0002-8798-4756","https://orcid.org/0000-0003-1134-2922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Shen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8798-4756","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022820783","display_name":"Farshid Dayyani","orcid":"https://orcid.org/0000-0002-4970-5189","observed_orcids":["https://orcid.org/0000-0002-4970-5189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farshid Dayyani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4970-5189","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021338173","display_name":"Jeremy D. Kratz","orcid":"https://orcid.org/0000-0003-1979-3955","observed_orcids":["https://orcid.org/0000-0003-1979-3955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy Kratz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1979-3955","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100713963","display_name":"Xinjun Liang","orcid":"https://orcid.org/0000-0002-5180-7926","observed_orcids":["https://orcid.org/0000-0002-5180-7926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinjun Liang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5180-7926","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077759445","display_name":"Funan Liu","orcid":"https://orcid.org/0000-0003-4762-8279","observed_orcids":["https://orcid.org/0000-0003-4762-8279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Funan Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4762-8279","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034711230","display_name":"Zhenning Wang","orcid":"https://orcid.org/0000-0003-0557-3097","observed_orcids":["https://orcid.org/0000-0003-0557-3097"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhenning Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0557-3097","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Laura Feller","orcid":"https://orcid.org/0009-0005-3156-2465","observed_orcids":["https://orcid.org/0009-0005-3156-2465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Feller","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-3156-2465","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055824335","display_name":"Eugenia Girda","orcid":"https://orcid.org/0000-0002-4787-5475","observed_orcids":["https://orcid.org/0000-0002-4787-5475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugenia Girda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4787-5475","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045553246","display_name":"Hongming Pan","orcid":"https://orcid.org/0000-0001-5034-3392","observed_orcids":["https://orcid.org/0000-0001-5034-3392","https://orcid.org/0009-0003-7751-6750"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongming Pan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5034-3392","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012940761","display_name":"Sunnie S. Kim","orcid":"https://orcid.org/0009-0008-3871-5112","observed_orcids":["https://orcid.org/0009-0008-3871-5112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunnie Kim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-3871-5112","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012853410","display_name":"Yanhong Deng","orcid":"https://orcid.org/0000-0001-6873-8026","observed_orcids":["https://orcid.org/0000-0001-6873-8026"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanhong Deng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6873-8026","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061337305","display_name":"Ting Deng","orcid":"https://orcid.org/0000-0003-4552-8039","observed_orcids":["https://orcid.org/0000-0003-4552-8039"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ting Deng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4552-8039","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100677110","display_name":"Tianshu Liu","orcid":"https://orcid.org/0000-0002-2318-2869","observed_orcids":["https://orcid.org/0000-0002-2318-2869"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tianshu Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2318-2869","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090977453","display_name":"John D. Powderly","orcid":"https://orcid.org/0000-0002-7608-0380","observed_orcids":["https://orcid.org/0000-0002-7608-0380"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Powderly","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7608-0380","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090718807","display_name":"Kristen Renee Spencer","orcid":"https://orcid.org/0000-0001-5577-3439","observed_orcids":["https://orcid.org/0000-0001-5577-3439"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristen Spencer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5577-3439","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053736790","display_name":"Reva Schneider","orcid":"https://orcid.org/0009-0003-5570-7601","observed_orcids":["https://orcid.org/0009-0003-5570-7601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reva Schneider","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-5570-7601","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039492614","display_name":"Jordan D. Berlin","orcid":"https://orcid.org/0000-0001-7571-2385","observed_orcids":["https://orcid.org/0000-0001-7571-2385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordan Berlin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7571-2385","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047407147","display_name":"Claire Xu","orcid":"https://orcid.org/0009-0007-4646-5435","observed_orcids":["https://orcid.org/0009-0007-4646-5435"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claire (Cong) Xu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-4646-5435","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052046806","display_name":"Christoph Matthias Ahlers","orcid":"https://orcid.org/0009-0009-3889-7195","observed_orcids":["https://orcid.org/0009-0009-3889-7195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christoph M. Ahlers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-3889-7195","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100740295","display_name":"Xuejun Liu","orcid":"https://orcid.org/0000-0001-8194-3067","observed_orcids":["https://orcid.org/0000-0001-8194-3067"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xuejun Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8194-3067","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111699932","display_name":"Jou-Ku Chung","orcid":"https://orcid.org/0009-0004-6676-8191","observed_orcids":["https://orcid.org/0009-0004-6676-8191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jou-Ku Chung","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-6676-8191","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034712498","display_name":"Peter Sabbatini","orcid":"https://orcid.org/0009-0007-8244-3700","observed_orcids":["https://orcid.org/0009-0007-8244-3700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Sabbatini","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-8244-3700","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100428902","display_name":"Jin-Young Park","orcid":"https://orcid.org/0000-0003-1434-4851","observed_orcids":["https://orcid.org/0000-0003-1434-4851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jinyoung Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1434-4851","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102508414","display_name":"Yangmi Lim","orcid":"https://orcid.org/0009-0000-4400-5514","observed_orcids":["https://orcid.org/0009-0000-4400-5514"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yangmi Lim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-4400-5514","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042129080","display_name":"Juyeun Jeon","orcid":"https://orcid.org/0000-0002-8365-5808","observed_orcids":["https://orcid.org/0000-0002-8365-5808"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juyeun Jeon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8365-5808","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109417246","display_name":"Yuan Meng","orcid":"https://orcid.org/0009-0005-6782-202X","observed_orcids":["https://orcid.org/0009-0005-6782-202X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Meng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-6782-202X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071611972","display_name":"Samuel Jacob Klempner","orcid":"https://orcid.org/0000-0002-4062-0808","observed_orcids":["https://orcid.org/0000-0002-4062-0808"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel J. Klempner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4062-0808","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.18619999289512634,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.012299999594688416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cldn18-2","display_name":"CLDN18.2","score":0.9480000138282776},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.9919999837875366},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.996999979019165},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7599999904632568},{"id":"https://openalex.org/keywords/immune-cell-subsets","display_name":"immune cell subsets","score":0.7419999837875366},{"id":"https://openalex.org/keywords/blood-samples","display_name":"blood samples","score":0.5640000104904175},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.5910000205039978},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.8939999938011169}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8108999729156494},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6347000002861023},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6277999877929688},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5989000201225281},{"id":"https://openalex.org/C3017910909","wikidata":"https://www.wikidata.org/wiki/Q618363","display_name":"Peripheral blood","level":2,"score":0.5608999729156494},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5504999756813049},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.41819998621940613},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4032000005245209},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39989998936653137},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35580000281333923},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33390000462532043},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3328999876976013},{"id":"https://openalex.org/C3018822202","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Patient data","level":2,"score":0.29980000853538513},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.287200003862381},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2815000116825104},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2806999981403351},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.2759999930858612},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.2709999978542328},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.2694000005722046},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.2689000070095062},{"id":"https://openalex.org/C2779979121","wikidata":"https://www.wikidata.org/wiki/Q211709","display_name":"Blood cell","level":2,"score":0.2687000036239624}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30750483","doi":"https://doi.org/10.1158/1078-0432.30750483","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30750483","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30750483","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_7_from_A_First-in-Human_Study_of_Givastomig_a_CLDN18_2_and_4-1BB_Bispecific_Antibody_as_Monotherapy_in_Patients_with_CLDN18_2-Positive_Advanced_or_Metastatic_Solid_Tumors/30750483","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30750483","doi":"https://doi.org/10.1158/1078-0432.30750483","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30750483","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4411807465","https://openalex.org/W4416845041","https://openalex.org/W4387811260","https://openalex.org/W4388042592","https://openalex.org/W4382139229","https://openalex.org/W4402560714","https://openalex.org/W4404067523","https://openalex.org/W4399325236","https://openalex.org/W4285006101","https://openalex.org/W4282918569"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"7.":[2],"Pharmacodynamic":[3],"effect":[4],"of":[5,13,27,47],"givastomig":[6],"on":[7],"peripheral":[8],"T":[9],"cell":[10,30,97],"subsets.":[11],"Heatmap":[12],"absolute":[14],"abundance":[15,24],"(%)":[16],"(panel":[17,25],"A)":[18],"and":[19,69,73,90],"change":[20],"from":[21,37,57],"baseline":[22],"in":[23],"B)":[26],"55":[28,95],"immune":[29,96],"subsets":[31,98],"among":[32],"238":[33,51],"blood":[34,52],"samples":[35,53],"collected":[36,56],"33":[38,58],"patients":[39,59,74],"treated":[40],"with":[41],"0.1":[42],"\u2013":[43],"15":[44],"mg/kg":[45],"Q2W":[46],"givastomig.":[48],"In":[49],"total,":[50],"(in":[54,99],"columns)":[55],"at":[60,88],"multiple":[61],"time":[62,71],"points":[63],"were":[64,75,101],"organized":[65],"by":[66,78],"patient":[67],"IDs":[68],"visit":[70],"points,":[72],"further":[76],"grouped":[77],"dosing":[79],"cohort,":[80],"cancer":[81],"type":[82],"(GC":[83],"vs.":[84],"non-GC),":[85],"CLDN18.2":[86],"status":[87],"baseline,":[89],"best":[91],"overall":[92],"response":[93],"(BOR).":[94],"rows)":[100],"hierarchically":[102],"clustered.":[103]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-12-01T00:00:00"}